A case report of successful transition from argatroban to warfarin using DOAC-stop in heparin induced thrombocytopenia (HIT)

Pathology. 2021 Oct;53(6):800-802. doi: 10.1016/j.pathol.2020.10.018. Epub 2021 Feb 17.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Anticoagulants / therapeutic use*
  • Arginine / analogs & derivatives*
  • Arginine / therapeutic use
  • Heparin / adverse effects*
  • Humans
  • Male
  • Pipecolic Acids / therapeutic use*
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Sulfonamides / therapeutic use*
  • Thrombocytopenia / chemically induced
  • Thrombocytopenia / drug therapy*
  • Warfarin / therapeutic use*

Substances

  • Anticoagulants
  • Pipecolic Acids
  • Platelet Aggregation Inhibitors
  • Sulfonamides
  • Warfarin
  • Heparin
  • Arginine
  • argatroban